An open-label extension study to determine the safety of pirnavanserin in patients with Parkinson's disease and psychosis

被引：0
|
作者：
Mills, R.
Johnson, A.
Bahr, D.
Williams, H.
Revell, S.
机构：
来源：
MOVEMENT DISORDERS | 2008年 / 23卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
672
引用
收藏
页码：S221 / S221
页数：1
相关论文
共 50 条
  • [31] Long-term safety and tolerability of memantine: an open-label extension study in patients with mild to moderate Alzheimer's disease
    Bakchine, S.
    Rainer, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S529 - S529
  • [32] Efficacy and safety of istradefylline in Parkinson's disease patients with postural abnormality: Results from a multicenter, open-label study in Japan
    Takahashi, M.
    Shimokawa, T.
    Koh, J.
    Takeshima, T.
    Yamashita, H.
    Kajimoto, Y.
    Mori, A.
    Ito, H.
    MOVEMENT DISORDERS, 2020, 35 : S484 - S484
  • [33] Safety and Efficacy of Continuous Apomorphine Infusion in Patients with Parkinson's disease: Results from a Phase 3, Open-label Study
    Isaacson, Stuart
    Espay, Alberto
    Pahwa, Rajesh
    Clinch, Thomas
    LeWitt, Peter
    NEUROLOGY, 2020, 94 (15)
  • [34] EFFICACY AND SAFETY OF ISTRADEFYLLINE IN PARKINSON'S DISEASE PATIENTS WITH POSTURAL ABNORMALITY: RESULTS FROM A MULTICENTER OPEN-LABEL STUDY IN JAPAN
    Takahashi, M.
    Shimokawa, T.
    Ko, J.
    Takeshima, T.
    Yamashita, H.
    Kajimoto, Y.
    Mori, A.
    Ito, H.
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : E60 - E61
  • [35] Risperidone in levodopa-induced psychosis in advanced Parkinson's disease: An open-label, long-term study
    Meco, G
    Alessandri, A
    Giustini, P
    Bonifati, V
    MOVEMENT DISORDERS, 1997, 12 (04) : 610 - 612
  • [36] Safety of adalimumab maintenance therapy in crohn's disease patients: open-label extension of charm and gain trials
    Colombel, J. F.
    Rutgeerts, P.
    Sandborn, W. J.
    Panaccione, R.
    Lau, W.
    Lomax, K. G.
    Pollack, P. F.
    GUT, 2008, 57 : A49 - A49
  • [37] Safety and efficacy of levodopa-carbidopa intestinal gel: results from an open-label extension study in Japanese, Korean and Taiwanese patients with advanced Parkinson's disease
    Murata, Miho
    Mihara, Masahito
    Hasegawa, Kazuko
    Jeon, Beomseok
    Tsai, Chon-Haw
    Nishikawa, Noriko
    Oeda, Tomoko
    Yokoyama, Masayuki
    Robieson, Weining Z.
    Chatamra, Krai
    Facheris, Maurizio F.
    Benesh, Janet
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2018, 11
  • [38] Long-term safety and tolerability of rotigotine transdermal system in patients with early-stage idiopathic Parkinson's disease: A prospective, open-label extension study
    Elmer, Lawrence W.
    Surmann, Erwin
    Boroojerdi, Babak
    Jankovic, Joseph
    PARKINSONISM & RELATED DISORDERS, 2012, 18 (05) : 488 - 493
  • [39] Efficacy and safety of galantamine (reminyl) in the treatment of dementia in patients with Parkinson's disease (open-label controlled trial)
    Litvinenko, In.
    Odinak, M. M.
    Mogilnaya, V. I.
    Emelin, A. Yu.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2007, 107 (12): : 25 - 33
  • [40] Laserlight cues for gait freezing in Parkinson's disease: An open-label study
    Donovan, S.
    Lim, C.
    Diaz, N.
    Browner, N.
    Rose, P.
    Sudarsky, L. R.
    Tarsy, D.
    Fahn, S.
    Simon, D. K.
    PARKINSONISM & RELATED DISORDERS, 2011, 17 (04) : 240 - 245
12345